CEO and CFO Exercise of Options and RPT

AI SummaryClose X

Eco Animal Health Group plc announced that CEO David Hallas exercised 7,333 share options and CFO Christopher Wilks exercised 5,649 share options, both at a nominal cost of 5p per share, with the transactions settled by existing shares from the Employee Benefit Trust. Following these exercises, David Hallas now holds 232,720 shares (0.34% of issued capital) and Christopher Wilks holds 183,835 shares (0.27% of issued capital), with the total number of ordinary shares remaining at 67,759,671. The company also confirmed a perpetual exclusive licence agreement with Vaxinano SAS for a sheep vaccine candidate, which is considered a related party transaction due to the Non-Executive Chairman's board membership at Vaxinano, but the terms are deemed fair and reasonable by the directors.

Disclaimer*

UK 100

Latest directors dealings